These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 33749986)

  • 1. Identification of mutation resistance coldspots for targeting the SARS-CoV2 main protease.
    Krishnamoorthy N; Fakhro K
    IUBMB Life; 2021 Apr; 73(4):670-675. PubMed ID: 33749986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy.
    Goyal B; Goyal D
    ACS Comb Sci; 2020 Jun; 22(6):297-305. PubMed ID: 32402186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dimer-monomer equilibrium of SARS-CoV-2 main protease is affected by small molecule inhibitors.
    Silvestrini L; Belhaj N; Comez L; Gerelli Y; Lauria A; Libera V; Mariani P; Marzullo P; Ortore MG; Palumbo Piccionello A; Petrillo C; Savini L; Paciaroni A; Spinozzi F
    Sci Rep; 2021 Apr; 11(1):9283. PubMed ID: 33927258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted design of drug binding sites in the main protease of SARS-CoV-2 reveals potential signatures of adaptation.
    Padhi AK; Tripathi T
    Biochem Biophys Res Commun; 2021 May; 555():147-153. PubMed ID: 33813274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric Regulation of 3CL Protease of SARS-CoV-2 and SARS-CoV Observed in the Crystal Structure Ensemble.
    Kidera A; Moritsugu K; Ekimoto T; Ikeguchi M
    J Mol Biol; 2021 Dec; 433(24):167324. PubMed ID: 34717972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization Rules for SARS-CoV-2 M
    Stoddard SV; Stoddard SD; Oelkers BK; Fitts K; Whalum K; Whalum K; Hemphill AD; Manikonda J; Martinez LM; Riley EG; Roof CM; Sarwar N; Thomas DM; Ulmer E; Wallace FE; Pandey P; Roy S
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32859008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new inactive conformation of SARS-CoV-2 main protease.
    Fornasier E; Macchia ML; Giachin G; Sosic A; Pavan M; Sturlese M; Salata C; Moro S; Gatto B; Bellanda M; Battistutta R
    Acta Crystallogr D Struct Biol; 2022 Mar; 78(Pt 3):363-378. PubMed ID: 35234150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput design of symmetrical dimeric SARS-CoV-2 main protease: structural and physical insights into hotspots for adaptation and therapeutics.
    Padhi AK; Tripathi T
    Phys Chem Chem Phys; 2022 Apr; 24(16):9141-9145. PubMed ID: 35411366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concordance of X-ray and AlphaFold2 Models of SARS-CoV-2 Main Protease with Residual Dipolar Couplings Measured in Solution.
    Robertson AJ; Courtney JM; Shen Y; Ying J; Bax A
    J Am Chem Soc; 2021 Nov; 143(46):19306-19310. PubMed ID: 34757725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
    Froggatt HM; Heaton BE; Heaton NS
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pH on stability of dimer structure of the main protease of coronavirus-2.
    Boonamnaj P; Pandey RB; Sompornpisut P
    Biophys Chem; 2022 Aug; 287():106829. PubMed ID: 35635893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
    Kumar Y; Singh H; Patel CN
    J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro selection and analysis of SARS-CoV-2 nirmatrelvir resistance mutations contributing to clinical virus resistance surveillance.
    Zhu Y; Yurgelonis I; Noell S; Yang Q; Guan S; Li Z; Hao L; Rothan H; Rai DK; McMonagle P; Baniecki ML; Greasley SE; Plotnikova O; Lee J; Nicki JA; Ferre R; Byrnes LJ; Liu W; Craig TK; Steppan CM; Liberator P; Soares HD; Allerton CMN; Anderson AS; Cardin RD
    Sci Adv; 2024 Jul; 10(30):eadl4013. PubMed ID: 39047088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct Observation of Protonation State Modulation in SARS-CoV-2 Main Protease upon Inhibitor Binding with Neutron Crystallography.
    Kneller DW; Phillips G; Weiss KL; Zhang Q; Coates L; Kovalevsky A
    J Med Chem; 2021 Apr; 64(8):4991-5000. PubMed ID: 33755450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Host Cellular Protein Substrates of SARS-COV-2 Main Protease.
    Miczi M; Golda M; Kunkli B; Nagy T; Tőzsér J; Mótyán JA
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33333742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Pyridone natural products as inhibitors of SARS-CoV-2 main protease.
    Forrestall KL; Burley DE; Cash MK; Pottie IR; Darvesh S
    Chem Biol Interact; 2021 Feb; 335():109348. PubMed ID: 33278462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of Nonstructural Protein 1 from SARS-CoV-2.
    Clark LK; Green TJ; Petit CM
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33234675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Docking of Azithromycin, Ritonavir, Lopinavir, Oseltamivir, Ivermectin and Heparin Interacting with Coronavirus Disease 2019 Main and Severe Acute Respiratory Syndrome Coronavirus-2 3C-Like Proteases.
    Arouche TDS; Martins AY; Ramalho TC; Júnior RNC; Costa FLP; Filho TSA; Neto AMJC
    J Nanosci Nanotechnol; 2021 Apr; 21(4):2075-2089. PubMed ID: 33500022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Silico Investigation of the SARS CoV2 Protease with Thymoquinone, the Major Constituent of Nigella Sativa.
    Kadil Y; Mouhcine M; Filali H
    Curr Drug Discov Technol; 2021; 18(4):570-573. PubMed ID: 32652915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 M
    Reinke PYA; Schubert R; Oberthür D; Galchenkova M; Rahmani Mashhour A; Günther S; Chretien A; Round A; Seychell BC; Norton-Baker B; Kim C; Schmidt C; Koua FHM; Tolstikova A; Ewert W; Peña Murillo GE; Mills G; Kirkwood H; Brognaro H; Han H; Koliyadu J; Schulz J; Bielecki J; Lieske J; Maracke J; Knoska J; Lorenzen K; Brings L; Sikorski M; Kloos M; Vakili M; Vagovic P; Middendorf P; de Wijn R; Bean R; Letrun R; Han S; Falke S; Geng T; Sato T; Srinivasan V; Kim Y; Yefanov OM; Gelisio L; Beck T; Doré AS; Mancuso AP; Betzel C; Bajt S; Redecke L; Chapman HN; Meents A; Turk D; Hinrichs W; Lane TJ
    Nat Commun; 2024 May; 15(1):3827. PubMed ID: 38714735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.